独家报道:美国疾控中心取消2月疫苗顾问会议,尚未公布新日期


2026年2月19日 美国东部时间下午6:32 / 路透社

作者:迈克尔·厄曼(Michael Erman)和朱莉·斯蒂恩胡伊森(Julie Steenhuysen)

[图片说明] 美国佐治亚州亚特兰大市疾控中心,免疫实践咨询委员会(ACIP)就儿童乙肝疫苗接种计划的建议进行投票,2025年12月5日。路透社/艾丽萨·波因特/资料图片 购买许可权(打开新标签页)

2月19日(路透社)——据美国卫生与公众服务部发言人透露,美国疾控中心(CDC)原定于本月晚些时候举行的疫苗咨询委员会会议将不会召开,且尚未公布新的会议日期。

美国卫生部长小罗伯特·F·肯尼迪(Robert F. Kennedy Jr.)正加大力度改写国家疫苗接种政策,包括撤销针对包括新冠和乙肝在内的六种儿童疫苗接种的广泛建议、深化联邦对各州疫苗豁免的支持,以及削减基于mRNA的疫苗研究资金。

订阅路透社健康动态通讯,了解最新医疗突破和医疗趋势。 点击此处注册。

广告 · 继续滚动查看

报告广告

根据疾控中心网站信息,负责制定疫苗接种建议的免疫实践咨询委员会(ACIP)原定于2月25日至27日举行会议,但尚未在《联邦公报》上发布会议通知,疾控中心也未公布会议议程。

美国卫生与公众服务部发言人安德鲁·尼克松(Andrew Nixon)表示:“我们将不会举行本月晚些时候的ACIP会议。一旦有进一步信息,我们会及时公布。”

该委员会的建议通常会影响美国的医疗保险覆盖范围、各州学校疫苗接种政策以及医生向家长和患者提供的建议。去年6月,肯尼迪解雇了该委员会全部17名成员后,该小组面临了多次重组。

一位知情人士透露,CDC正在考虑将会议重新安排在3月。该委员会通常每年至少召开三次会议。

这一变动发生在CDC领导层调整之际。一位特朗普政府官员周三表示,美国国立卫生研究院(NIH)院长杰伊·巴塔查里亚(Jay Bhattacharya)将接任美国疾控中心代理主任,接替现任代理主任吉姆·奥尼尔(Jim O’Neill)。

美国主要医疗团体已请求联邦法官阻止该委员会举行会议。这些团体正在提起诉讼,挑战肯尼迪制定的政策,称这些政策将降低疫苗接种率。

他们辩称,ACIP被与肯尼迪反疫苗观点一致的人主导,违反了《联邦咨询委员会法》关于委员会应保持公平平衡且不受不当影响的规定。

新泽西州迈克尔·厄曼报道,芝加哥朱莉·斯蒂恩胡伊森报道;卡罗琳·休默(Caroline Humer)和大卫·格雷戈里奥(David Gregorio)编辑

我们的标准:路透社信托原则(打开新标签页)


(注:原文中的“节点运行失败”为技术错误提示,已删除。)

Exclusive: US CDC cancels February vaccine adviser meeting, no new one set yet

February 19, 2026 6:32 PM UTC / Reuters

By Michael Erman and Julie Steenhuysen

节点运行失败

The Advisory Committee on Immunization Practices (ACIP) votes on the recommendation of the childhood hepatitis B vaccine schedule at the Centers for Disease Control and Prevention, in Atlanta, Georgia, U.S., December 5, 2025. REUTERS/Alyssa Pointer/File Photo Purchase Licensing Rights, opens new tab

Feb 19 (Reuters) – A U.S. vaccine advisory committee meeting scheduled for later this month by the Centers for Disease Control and Prevention will not be held, with no new dates announced, according to a spokesman for the Department of Health and Human Services.

U.S. Health Secretary Robert F. Kennedy Jr. has stepped up efforts to rewrite national vaccination policy, including dropping broad recommendations for six childhood shots including COVID and hepatitis B, deepening federal support for states’ vaccine exemptions, and cutting funding for mRNA-based vaccine research.

Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.

Advertisement · Scroll to continue

Report Ad

The Advisory Committee on Immunization Practices (ACIP), which makes recommendations for who should get which vaccines, had been scheduled to meet from February 25-27, according to the CDC’s website. But no Federal Register notice had been made to announce the meeting, nor had the CDC posted an agenda.

“We will not hold the ACIP meeting later this month. Further information will be shared as available,” HHS spokesman Andrew Nixon said.

The committee’s recommendations typically have affected U.S. health insurance coverage, state policies on vaccines needed for schools and how physicians advise parents and patients. The panel faced multiple revamps last year, after Kennedy fired all its 17 members in June.

Advertisement · Scroll to continue

One source familiar with the matter said the CDC is considering rescheduling the meeting for March. The committee generally meets at least three times a year.

The change comes as leadership at the CDC is shifting. National Institutes of Health Director Jay Bhattacharya will step in as acting director of the Centers for Disease Control and Prevention, a Trump administration official said on Wednesday, replacing current acting director Jim O’Neill.

Major U.S. medical groups have asked a federal judge to prevent the panel from holding the meeting. The groups are suing to challenge policies adopted under Kennedy that they say will lower vaccination rates.

They argue the ACIP is dominated by people aligned with Kennedy’s anti-vaccine views, in violation of the Federal Advisory Committee Act’s mandates that it be fairly balanced and free of inappropriate influence.

节点运行失败

Reporting by Michael Erman in New Jersey and Julie Steenhuysen in Chicago; Editing by Caroline Humer and David Gregorio

Our Standards: The Thomson Reuters Trust Principles., opens new tab

评论

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注